OBJECTIVE: To evaluate if pRCCs demonstrate intracellular lipid (i-lipid) at chemical-shift (CS) MRI, and assess T2W-MRI and pathologic characteristics. METHODOLOGY: Sixty-two patients with a pRCC diagnosis underwent MRI over 11 years (IRB-approved). Two radiologists independently assessed for presence of i-lipid on CS-MRI and homogeneity on T2W-MRI. Inter-observer agreement was assessed via an intraclass correlation and results were compared using the Chi-square test. Discordant cases were reviewed to establish consensus. T2W SI-ratios (SI.tumor/SI.kidney) and CS-SI index were compared using independent t-tests and Spearman correlation. Two pathologists re-evaluated the histopathology. RESULTS: Nine of the 62 pRCCs (14.5%) demonstrated i-lipid; agreement was moderate (ICC = 0.63). Pathology review depicted clear cells in four tumours and foamy histiocytes in five tumours. 25.8-35.4% (ICC = 0.65) of tumours were homogeneous on T2W-MRI. No pRCC with i-lipid was considered homogeneous (p = 0.01-0.04). Overall, T2W SI-ratio and CS-SI index were 0.89 (±0.29) and -3.63 % (-7.27 to 11.42). pRCC with i-lipid had significantly higher T2W SI-ratio (p = 0.003). There was a correlation between the CS-SI index and T2W SI-ratio, (r = 0.44, p < 0.001). CONCLUSIONS: Intracellular lipid is uncommonly detected in pRCCs due to clear cell changes and foamy histiocytes. These tumours are associated with heterogeneously-increased SI in T2W-MRI. KEY POINTS: • A minority of pRCCs demonstrate intracellular lipid in CS-MRI. • Quantitatively, intracellular lipid in pRCCs is minimal (<25%). • Intracellular lipid in pRCCs are from clear cell heterogeneity or foamy histiocytes. • pRCCs with intracellular lipid are heterogeneously hyperintense at T2W-MRI. • pRCCs that are homogeneously hypointense at T2W-MRI do not contain intracellular lipid.
OBJECTIVE: To evaluate if pRCCs demonstrate intracellular lipid (i-lipid) at chemical-shift (CS) MRI, and assess T2W-MRI and pathologic characteristics. METHODOLOGY: Sixty-two patients with a pRCC diagnosis underwent MRI over 11 years (IRB-approved). Two radiologists independently assessed for presence of i-lipid on CS-MRI and homogeneity on T2W-MRI. Inter-observer agreement was assessed via an intraclass correlation and results were compared using the Chi-square test. Discordant cases were reviewed to establish consensus. T2W SI-ratios (SI.tumor/SI.kidney) and CS-SI index were compared using independent t-tests and Spearman correlation. Two pathologists re-evaluated the histopathology. RESULTS: Nine of the 62 pRCCs (14.5%) demonstrated i-lipid; agreement was moderate (ICC = 0.63). Pathology review depicted clear cells in four tumours and foamy histiocytes in five tumours. 25.8-35.4% (ICC = 0.65) of tumours were homogeneous on T2W-MRI. No pRCC with i-lipid was considered homogeneous (p = 0.01-0.04). Overall, T2W SI-ratio and CS-SI index were 0.89 (±0.29) and -3.63 % (-7.27 to 11.42). pRCC with i-lipid had significantly higher T2W SI-ratio (p = 0.003). There was a correlation between the CS-SI index and T2W SI-ratio, (r = 0.44, p < 0.001). CONCLUSIONS: Intracellular lipid is uncommonly detected in pRCCs due to clear cell changes and foamy histiocytes. These tumours are associated with heterogeneously-increased SI in T2W-MRI. KEY POINTS: • A minority of pRCCs demonstrate intracellular lipid in CS-MRI. • Quantitatively, intracellular lipid in pRCCs is minimal (<25%). • Intracellular lipid in pRCCs are from clear cell heterogeneity or foamy histiocytes. • pRCCs with intracellular lipid are heterogeneously hyperintense at T2W-MRI. • pRCCs that are homogeneously hypointense at T2W-MRI do not contain intracellular lipid.
Authors: Timothy G Schuster; Mark R Ferguson; David E Baker; John D Schaldenbrand; M Hugh Solomon Journal: AJR Am J Roentgenol Date: 2004-11 Impact factor: 3.959
Authors: Nicole Hindman; Long Ngo; Elizabeth M Genega; Jonathan Melamed; Jesse Wei; Julia M Braza; Neil M Rofsky; Ivan Pedrosa Journal: Radiology Date: 2012-09-25 Impact factor: 11.105
Authors: Peter Beddy; Elizabeth M Genega; Long Ngo; Nicole Hindman; Jesse Wei; Andrea Bullock; Rupal S Bhatt; Michael B Atkins; Ivan Pedrosa Journal: Clin Genitourin Cancer Date: 2013-10-19 Impact factor: 2.872
Authors: Kien T Mai; Hamidreza Faraji; Darren Desantis; Susan J Robertson; Eric C Belanger; Joelle Levac Journal: Virchows Arch Date: 2009-12-22 Impact factor: 4.064
Authors: Nicola Schieda; Marc Dilauro; Bardia Moosavi; Taryn Hodgdon; Gregory O Cron; Matthew D F McInnes; Trevor A Flood Journal: Eur Radiol Date: 2015-10-20 Impact factor: 5.315
Authors: Shaheed W Hakim; Nicola Schieda; Taryn Hodgdon; Matthew D F McInnes; Marc Dilauro; Trevor A Flood Journal: Eur Radiol Date: 2015-06-03 Impact factor: 5.315
Authors: F Cornelis; D Ambrosetti; L Rocher; L E Derchi; B Renard; P Puech; M Claudon; O Rouvière; S Ferlicot; C Roy; M Yacoub; N Grenier; J C Bernhard Journal: Eur Radiol Date: 2016-06-22 Impact factor: 5.315
Authors: Nicola Schieda; Matthew S Davenport; Ivan Pedrosa; Atul Shinagare; Hersch Chandarana; Nicole Curci; Ankur Doshi; Gary Israel; Erick Remer; Jane Wang; Stuart G Silverman Journal: J Magn Reson Imaging Date: 2019-01-28 Impact factor: 4.813